OnKure Therapeutics (OKUR)
NASDAQ:OKUR
US Market
Holding OKUR?
Track your performance easily

OnKure Therapeutics (OKUR) Financial Statements

242 Followers

OnKure Therapeutics Financial Overview

OnKure Therapeutics's market cap is currently ―. The company's EPS TTM is $-16.851; its P/E ratio is -1.03; OnKure Therapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.69M$ -5.36M$ -9.56M$ -20.89M$ -19.53M
EBITDA$ -3.68M$ -4.44M$ -9.55M$ -20.84M$ -18.72M
Net Income Common Stockholders$ -3.69M$ -5.36M$ -8.43M$ -19.20M$ -19.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 76.67M$ 76.67M$ 82.83M$ 125.61M$ 142.68M
Total Assets$ 77.64M$ 78.72M$ 84.64M$ 130.39M$ 148.04M
Total Debt$ 665.00K$ 823.00K$ 907.00K$ 1.14M$ 1.22M
Net Debt$ -76.00M$ -75.85M$ -81.93M$ -124.48M$ -141.46M
Total Liabilities$ 3.63M$ 1.85M$ 3.40M$ 15.44M$ 15.51M
Stockholders Equity$ 74.02M$ 76.87M$ 81.24M$ 114.94M$ 132.53M
Cash Flow-
Free Cash Flow$ -2.28M$ -6.81M$ -21.01M$ -18.79M$ -16.12M
Operating Cash Flow$ -2.28M$ -6.81M$ -21.01M$ -18.77M$ -16.11M
Investing Cash Flow$ 25.00M$ 22.49M$ 13.76M$ 21.25M$ -69.01M
Financing Cash Flow$ 2.00M$ -89.00K-$ 173.00K$ 63.81M
Currency in USD

OnKure Therapeutics Earnings and Revenue History

OnKure Therapeutics Debt to Assets

OnKure Therapeutics Cash Flow

OnKure Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis